Dergiler / The Anatolian Journal of Cardiology / 2019 / Cilt: 22 - Sayı: 3

The cystathionine γ-lyase/hydrogen sulfide pathway mediates the trimetazidine-induced protection of H9c2 cells against hypoxia/ reoxygenation-induced apoptosis and oxidative stress

Sayfa
102–111
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These effects were also reversed by si-CSE.Conclusion: This study revealed that the CSE/H2 S pathway mediates the trimetazidine-induced protection of H9c2 cardiomyocytes against H/Rinduced damage by inhibiting apoptosis and oxidative stress. (Anatol J Cardiol 2019; 22: 102-11)

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Trimetazidine is a piperazine-derived metabolic agent.
📊
Temel Bulgular & Veri:In addition, studies confirm that the cystathionine γ-lyase (CSE)/hydrogen sulfide (H2 S) pathway serves a beneficent role in attenuating myocardial I/R injury.
💡
Sonuç & Katkı:These effects were also reversed by si-CSE.Conclusion: This study revealed that the CSE/H2 S pathway mediates the trimetazidine-induced protection of H9c2 cardiomyocytes against H/Rinduced damage by inhibiting apoptosis and oxidative stress. (Anatol J Cardiol 2019; 22: 102-11)
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Trimetazidine is a piperazine-derived metabolic agent. It exerts cardioprotective effects against myocardial ischemia/reperfusion (I/R) injury. In addition, studies confirm that the cystathionine γ-lyase (CSE)/hydrogen sulfide (H2 S) pathway serves a beneficent role in attenuating myocardial I/R injury. However, the underlying role of the CSE/H2 S pathway in the trimetazidine-induced protection against myocardial I/R injury remains elusive. Therefore, this study investigated whether trimetazidine ameliorates hypoxia/reoxygenation (H/R)-induced H9c2 cardiomyocyte injuries in an in vitro cell model of myocardial I/R injury, by enhancing the CSE/H2 S pathway.Methods: The H9c2 cell viability was determined with a cell counting Kit-8.Results: Trimetazidine significantly increased the cell viability and decreased lactate dehydrogenase (LDH) release in H/R-treated H9c2 cells. Additionally, trimetazidine increased the H2 S levels and the CSE mRNA and protein levels, promoting the CSE/H2 S pathway under H/R conditions. The inhibition of the CSE/H2 S pathway, induced by transfection with specific siRNA against human CSE (si-CSE), eliminated the trimetazidineinduced upregulation of cell viability, downregulation of LDH release, increase of caspase-3 activity and apoptosis regulator BAX expression, and the decrease of apoptosis regulator Bcl-2 expression, which suggests involvement of the CSE/H2 S pathway in trimetazidine-induced cardioprotection. Furthermore, trimetazidine mitigated the H/R-induced increase in reactive oxygen species production and NADPH oxidase 2 expression, and decrease in superoxide dismutase activity and glutathione level, in H9c2 cells. These effects were also reversed by si-CSE.Conclusion: This study revealed that the CSE/H2 S pathway mediates the trimetazidine-induced protection of H9c2 cardiomyocytes against H/Rinduced damage by inhibiting apoptosis and oxidative stress. (Anatol J Cardiol 2019; 22: 102-11)

🔖

Bu Makaleye Atıf Yap

ZHENG, W., LIU, C. (2019). The cystathionine γ-lyase/hydrogen sulfide pathway mediates the trimetazidine-induced protection of H9c2 cells against hypoxia/ reoxygenation-induced apoptosis and oxidative stress. The Anatolian Journal of Cardiology, Cilt: 22 - Sayı: 3, 102–111. https://ajindex.com/articles/366799

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Flaxman A, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation 2014; 129: 1493-501
  2. Thind GS, Agrawal PR, Hirsh B, Saravolatz L, Chen-Scarabelli C, Narula J, et al. Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: scope and limitations. Future Cardiol 2015; 11: 61-76
  3. Kunecki M, Plazak W, Podolec P, Golba KS. Effects of endogenous cardioprotective mechanisms on ischemia-reperfusion injury. Postepy Hig Med Dosw (Online) 2017; 71: 20-31
  4. Yang Q, He GW, Underwood MJ, Yu CM. Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. Am J Transl Res 2016; 8: 765-77
  5. Ma N, Bai J, Zhang W, Luo H, Zhang X, Liu D, et al. Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA21 expression, Akt and the Bcl2/Bax pathway. Mol Med Rep 2016; 14: 4216-22
  6. Hu X, Yang J, Wang Y, Zhang Y, Ii M, Shen Z, et al. Mesenchymal stem cells preconditioned with trimetazidine promote neovascularization of hearts under hypoxia/reoxygenation injury. Int J Clin Exp Med 2015; 8: 16991-7005
  7. Martins GF, Siqueira Filho AG, Santos JB, Assunção CR, Bottino F, Carvalho KG, et al. Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting. Arq Bras Cardiol 2011; 97: 209-16
  8. Wallace JL, Wang R. Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter. Nat Rev Drug Discov 2015; 14: 329-45
  9. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, et al. H2 S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004; 313: 362-8
  10. Karwi QG, Bice JS, Baxter GF. Pre- and postconditioning the heart with hydrogen sulfide (H2 S) against ischemia/reperfusion injury in vivo: a systematic review and meta-analysis. Basic Res Cardiol 2017; 113: 6
  11. Dongó E, Hornyák I, Benko Z, Kiss L. The cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury (review). Acta Physiol Hung 2011; 98: 369-81
  12. Hu B, Xu G, Zheng Y, Tong F, Qian P, Pan X, et al. Chelerythrine Attenuates Renal Ischemia/Reperfusion-induced Myocardial Injury by Activating CSE/H2 S via PKC/NF-κB Pathway in Diabetic Rats. Kidney Blood Press Res 2017; 42: 379-88
  13. Donnarumma E, Ali MJ, Rushing AM, Scarboroug